These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 23278988)
1. Prognostic significance of Ror2 and Wnt5a expression in medulloblastoma. Lee SE; Lim SD; Kang SY; Suh SB; Suh YL Brain Pathol; 2013 Jul; 23(4):445-53. PubMed ID: 23278988 [TBL] [Abstract][Full Text] [Related]
2. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells. Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266 [TBL] [Abstract][Full Text] [Related]
3. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis. Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546 [TBL] [Abstract][Full Text] [Related]
4. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells. Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592 [TBL] [Abstract][Full Text] [Related]
5. Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer. Lu C; Wang X; Zhu H; Feng J; Ni S; Huang J Oncotarget; 2015 Sep; 6(28):24912-21. PubMed ID: 26305508 [TBL] [Abstract][Full Text] [Related]
6. Wnt5a, Ryk and Ror2 expression in glioblastoma subgroups. Kim Y; Hong M; Do IG; Ha SY; Lee D; Suh YL Pathol Res Pract; 2015 Dec; 211(12):963-72. PubMed ID: 26596412 [TBL] [Abstract][Full Text] [Related]
7. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma. O'Connell MP; Fiori JL; Xu M; Carter AD; Frank BP; Camilli TC; French AD; Dissanayake SK; Indig FE; Bernier M; Taub DD; Hewitt SM; Weeraratna AT Oncogene; 2010 Jan; 29(1):34-44. PubMed ID: 19802008 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas. Li L; Ying J; Tong X; Zhong L; Su X; Xiang T; Shu X; Rong R; Xiong L; Li H; Chan AT; Ambinder RF; Guo Y; Tao Q Cell Mol Life Sci; 2014 Jun; 71(11):2179-92. PubMed ID: 24158497 [TBL] [Abstract][Full Text] [Related]
9. Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling. Henry C; Quadir A; Hawkins NJ; Jary E; Llamosas E; Kumar D; Daniels B; Ward RL; Ford CE J Cancer Res Clin Oncol; 2015 Feb; 141(2):243-54. PubMed ID: 25209439 [TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of Wnt signaling pathway in keloid pathogenesis. Igota S; Tosa M; Murakami M; Egawa S; Shimizu H; Hyakusoku H; Ghazizadeh M Int J Med Sci; 2013; 10(4):344-54. PubMed ID: 23471552 [TBL] [Abstract][Full Text] [Related]
14. Dissection of Wnt5a-Ror2 signaling leading to matrix metalloproteinase (MMP-13) expression. Yamagata K; Li X; Ikegaki S; Oneyama C; Okada M; Nishita M; Minami Y J Biol Chem; 2012 Jan; 287(2):1588-99. PubMed ID: 22128168 [TBL] [Abstract][Full Text] [Related]
15. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. Mikels AJ; Nusse R PLoS Biol; 2006 Apr; 4(4):e115. PubMed ID: 16602827 [TBL] [Abstract][Full Text] [Related]
16. The Meckel-Gruber syndrome protein TMEM67 controls basal body positioning and epithelial branching morphogenesis in mice via the non-canonical Wnt pathway. Abdelhamed ZA; Natarajan S; Wheway G; Inglehearn CF; Toomes C; Johnson CA; Jagger DJ Dis Model Mech; 2015 Jun; 8(6):527-41. PubMed ID: 26035863 [TBL] [Abstract][Full Text] [Related]
17. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling. Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643 [TBL] [Abstract][Full Text] [Related]
18. Ror2/Frizzled complex mediates Wnt5a-induced AP-1 activation by regulating Dishevelled polymerization. Nishita M; Itsukushima S; Nomachi A; Endo M; Wang Z; Inaba D; Qiao S; Takada S; Kikuchi A; Minami Y Mol Cell Biol; 2010 Jul; 30(14):3610-9. PubMed ID: 20457807 [TBL] [Abstract][Full Text] [Related]
19. Thyroid hormone-regulated Wnt5a/Ror2 signaling is essential for dedifferentiation of larval epithelial cells into adult stem cells in the Xenopus laevis intestine. Ishizuya-Oka A; Kajita M; Hasebe T PLoS One; 2014; 9(9):e107611. PubMed ID: 25211363 [TBL] [Abstract][Full Text] [Related]
20. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Ellison DW; Dalton J; Kocak M; Nicholson SL; Fraga C; Neale G; Kenney AM; Brat DJ; Perry A; Yong WH; Taylor RE; Bailey S; Clifford SC; Gilbertson RJ Acta Neuropathol; 2011 Mar; 121(3):381-96. PubMed ID: 21267586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]